Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Osteoporos Int ; 27(2): 457-62, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26252978

ABSTRACT

UNLABELLED: Trabecular bone scores (TBS) have recently been developed as a diagnostic tool to assess bone texture. We studied thyroid status and TBS in a population-based cohort and demonstrated that high-normal thyroxine levels are associated with low TBS in healthy euthyroid postmenopausal women. INTRODUCTION: Increased thyroid hormone levels affect bone mineral density (BMD) and, if untreated, increase the risk of fracture. However, the relationship between thyroid function and bone microarchitecture has not yet been established. Trabecular bone scores (TBS) are gray-level textural measurements of dual energy X-ray absorptiometry (DXA) images. The TBS has been proposed as an indirect index of bone microarchitecture. The goal of this study was to characterize the relationship between thyroid function and TBS in euthyroid men and postmenopausal euthyroid women. METHODS: A total of 1376 euthyroid subjects (648 postmenopausal women and 728 men) were recruited from a community-based cohort in Korea. Free thyroxine (fT4) levels, thyroid stimulating hormone (TSH) levels, BMD, and TBS were measured and compared. RESULTS: There was no significant relationship between either fT4 or TSH levels and BMD in men and women. Multiple linear regression analysis showed that high-normal fT4 levels were negatively correlated with TBS (ß = -0.111; P = 0.002, after adjusting for both age and body mass index [BMI]) in postmenopausal women. In men, however, there was no significant correlation between fT4 levels and TBS. TSH levels were not significantly associated with TBS in either men or women. CONCLUSION: Higher fT4 levels within the normal reference range are associated with deterioration of trabecular microarchitecture in healthy euthyroid postmenopausal women.


Subject(s)
Hyperthyroidism/complications , Osteoporosis, Postmenopausal/etiology , Thyroxine/blood , Absorptiometry, Photon/methods , Aged , Aged, 80 and over , Bone Density/physiology , Cohort Studies , Female , Femur Neck/physiopathology , Hip Joint/physiopathology , Humans , Hyperthyroidism/blood , Hyperthyroidism/physiopathology , Lumbar Vertebrae/physiopathology , Male , Middle Aged , Osteoporosis, Postmenopausal/blood , Osteoporosis, Postmenopausal/physiopathology , Sex Factors , Thyroid Function Tests/methods , Thyrotropin/blood
3.
Thorax ; 61(1): 41-7, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16244090

ABSTRACT

BACKGROUND: Airway hyperresponsiveness in asthmatics is considered to be one of the major consequences of airway inflammation and remodelling. Airway responsiveness is normal in patients with eosinophilic bronchitis (EB), despite eosinophilic inflammation of the airways comparable to that which occurs in asthmatics. Comparisons between asthma and EB should clarify the changes in airway morphology that are related specifically to AHR in asthmatics. METHODS: Eighteen asthmatic patients, 15 patients with EB, and 11 healthy subjects were recruited. Airway wall area percentage (WA%), centrilobular prominence, and air trapping were compared using thin slice section computed tomography. RESULTS: WA% was significantly greater in asthmatics than in patients with EB (72 (3.1)% v 54 (2.1)%, p = 0.032) and was similar in EB patients and controls (54 (2.1)% v 57 (1.8)%, p>0.05). Centrilobular prominence and air trapping were similar in EB patients and asthmatics and were significantly greater than in controls. CONCLUSION: WA% rather than air trapping or centrilobular prominence may be associated with the airway hyperresponsiveness that occurs in asthmatics but not in patients with EB.


Subject(s)
Asthma/diagnostic imaging , Bronchial Hyperreactivity/diagnostic imaging , Bronchitis/diagnostic imaging , Eosinophilia/diagnostic imaging , Asthma/pathology , Asthma/physiopathology , Bronchi/pathology , Bronchial Hyperreactivity/pathology , Bronchial Hyperreactivity/physiopathology , Bronchitis/pathology , Bronchitis/physiopathology , Case-Control Studies , Eosinophilia/pathology , Eosinophilia/physiopathology , Female , Forced Expiratory Volume/physiology , Humans , Male , Middle Aged , Observer Variation , Tomography, Spiral Computed/methods , Vital Capacity/physiology
4.
J Biol Chem ; 275(2): 959-68, 2000 Jan 14.
Article in English | MEDLINE | ID: mdl-10625633

ABSTRACT

Holo-(acyl carrier protein) synthase (AcpS) post-translationally modifies apoacyl carrier protein (apoACP) via transfer of 4'-phosphopantetheine from coenzyme A (CoA) to the conserved serine 36 gamma-OH of apoACP. The resulting holo-acyl carrier protein (holo-ACP) is then active as the central coenzyme of fatty acid biosynthesis. The acpS gene has previously been identified and shown to be essential for Escherichia coli growth. Earlier mutagenic studies isolated the E. coli MP4 strain, whose elevated growth requirement for CoA was ascribed to a deficiency in holoACP synthesis. Sequencing of the acpS gene from the E. coli MP4 strain (denoted acpS1) showed that the AcpS1 protein contains a G4D mutation. AcpS1 exhibited a approximately 5-fold reduction in its catalytic efficiency when compared with wild type AcpS, accounting for the E. coli MP4 strain phenotype. It is shown that a conditional acpS mutant accumulates apoACP in vivo under nonpermissive conditions in a manner similar to the E. coli MP4 strain. In addition, it is demonstrated that the gene product, YhhU, of a previously identified E. coli open reading frame can completely suppress the acpS conditional, lethal phenotype upon overexpression of the protein, suggesting that YhhU may be involved in an alternative pathway for phosphopantetheinyl transfer and holoACP synthesis in E. coli.


Subject(s)
Escherichia coli/enzymology , Pantetheine/analogs & derivatives , Transferases (Other Substituted Phosphate Groups)/genetics , Transferases (Other Substituted Phosphate Groups)/metabolism , Amino Acid Substitution , Cloning, Molecular , Concanavalin A/metabolism , Escherichia coli/genetics , Escherichia coli/growth & development , Genetic Complementation Test , Kinetics , Pantetheine/metabolism , Plasmids , Point Mutation , Protein Processing, Post-Translational , Recombinant Proteins/metabolism , Tetracycline/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...